Announcements
26 March 2025
Cells 2024 Outstanding Reviewer Award—Winners Announced
26 March 2025
Cells 2024 Young Investigator Award—Winner Announced
21 March 2025
World Down Syndrome Day, 21 March 2025
This year, World Down Syndrome Day will be celebrated on 21 March 2025. Each year, approximately 3,000 to 5,000 children are born with this chromosome disorder. In 2025, we call for people around the world to “end the stereotypes”.
Aiming at improving the quality of life of people with Down syndrome and propelling the scientific development in this field, we would like to recommend some related articles, Special Issues, and journals in MDPI as suitable communication platforms for you. We believe that sharing research like this can help raise awareness of Down syndrome.
 |
 |
 |
 |
 |
 |
 |
 |
 |
“When Language Is Not Enough: How to Explain ToM Abilities of Individuals with Williams Syndrome and Down Syndrome”
by Claire Touchet, Régis Pochon and Laure Ibernon
Disabilities 2025, 5(1), 4; https://doi.org/10.3390/disabilities5010004
“Assessing Uveitis Risk following Pediatric Down Syndrome Diagnosis: A TriNetX Database Study”
by Alan Y. Hsu, Yu-Hsun Wang, Chun-Ju Lin, You-Ling Li, Ning-Yi Hsia, Chun-Ting Lai, Hou-Ting Kuo, Huan-Sheng Chen, Yi-Yu Tsai and James Cheng-Chung Wei
Medicina 2024, 60(5), 710; https://doi.org/10.3390/medicina60050710
“Impact of Resistance Training on Body Composition and Physical Function in Individuals with Down Syndrome: A Meta-Analysis”
by Hou-Ting Kuo, Ting-Hsu Lee, Li-An Su, Li-Yun Wu, Ping-Yan Mao and Ciao-Ci Yang
Diagnostics 2024, 14(23), 2620; https://doi.org/10.3390/diagnostics14232620
“The Role of Tau Pathology in Alzheimer’s Disease and Down Syndrome”
by Ann-Charlotte Granholm and Eric D. Hamlett
J. Clin. Med. 2024, 13(5), 1338; https://doi.org/10.3390/jcm13051338
“Astrocytic Alterations and Dysfunction in Down Syndrome: Focus on Neurogenesis, Synaptogenesis, and Neural Circuits Formation”
by Beatrice Uguagliati and Mariagrazia Grilli
Cells 2024, 13(24), 2037; https://doi.org/10.3390/cells13242037
“Lipid Profile, Eating Habit, and Physical Activity in Children with Down Syndrome: A Prospective Study”
by Luca Pecoraro, Melissa Zadra, Francesco Cavallin, Silvana Lauriola, Giorgio Piacentini and Angelo Pietrobelli
Diseases 2024, 12(4), 68; https://doi.org/10.3390/diseases12040068
“Impact of Physical Activity on Autonomy and Quality of Life in Individuals with Down Syndrome: A Systematic Review”
by Antonio Muñoz-Llerena, Laura Ladrón-de-Guevara, Daniel Medina-Rebollo and Virginia Alcaraz-Rodríguez
Healthcare 2024, 12(2), 181; https://doi.org/10.3390/healthcare12020181
“Health Checks for People with Down Syndrome: A Pooled Analysis of Three Randomized Controlled Trials”
by Robert S. Ware, Catherine Franklin, Lyn McPherson and Nicholas G. Lennox
Disabilities 2024, 4(1), 101-110; https://doi.org/10.3390/disabilities4010007
“DNMT3B rs2424913 as a Risk Factor for Congenital Heart Defects in Down Syndrome”
by Dijana Majstorović, Anita Barišić, Ivana Babić Božović, Iva Bilić Čače, Neven Čače, Mauro Štifanić and Jadranka Vraneković
Genes 2023, 14(3), 576; https://doi.org/10.3390/genes14030576
“Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules”
by Lanzillotta, Chiara, and Fabio Di Domenico
Biomolecules 2021, 11(2), 266; https://doi.org/10.3390/biom11020266
“Role of 3-Mercaptopyruvate Sulfurtransferase in the Regulation of Proliferation and Cellular Bioenergetics in Human Down Syndrome Fibroblasts”
by Panagaki, Theodora, Elisa B. Randi, and Csaba Szabo
Biomolecules 2020, 10(4), 653; https://doi.org/10.3390/biom10040653
27 February 2025
More than 300 MDPI Journals Indexed in Web of Science
MDPI is pleased to share a significant milestone in its mission to advance scholarly research and promote the dissemination of knowledge—300+ MDPI journals are now indexed in Web of Science (WoS). This milestone highlights the global recognition, interdisciplinary impact and enhanced visibility of our journals. It also reflects our adherence to rigorous editorial standards, scientific integrity, and our mission to foster open scientific exchange in all forms, across all disciplines.
To explore the full list of our journals indexed in WoS, please visit https://www.mdpi.com/about/journals/wos. Beyond expanding the coverage of our publications in the leading academic databases, we are dedicated to ensuring that our journals are included in as many scope-specific databases as possible. This increases the visibility of our authors’ work and extends the reach of their significant data.
This milestone would not have been possible without the efforts and expertise of our academic editors, reviewers and authors. Their commitment and collaboration have been instrumental in creating an inclusive, accessible, and impactful publishing platform. We also extend our gratitude to the global research community for their trust as we continue to break new ground in academic publishing. This milestone is not just a celebration of MDPI’s progress but also recognition of the collective strides made by researchers worldwide.
As we celebrate this remarkable accomplishment, MDPI remains steadfast in its commitment to open access publishing and ensuring that high-quality research reaches and inspires a global audience.
26 February 2025
Welcoming the New Early Career Editorial Board Members of Cells
Cells (ISSN: 2073-4409) is pleased to add the following 57 researchers to the 2025 Early Career Editorial Board and congratulate them on becoming part of the Cells community!
 |
Name: Dr. Carmine Siniscalchi |
 |
Name: Dr. Liberalis Debraj Boila |
 |
Name: Dr. Dongheon Lee |
 |
Name: Dr. Sayantani Sinha |
 |
Name: Dr. Chiara Di Berardino |
 |
Name: Dr. Raffaele Pellegrino |
 |
Name: Dr. Angelo Canciello |
 |
Name: Dr. Paulina Adamska |
 |
Name: Dr. Avik Dutta |
 |
Name: Dr. Alessandra Ferraresi |
 |
Name: Dr. Yuhua Wei |
 |
Name: Dr. Erica Pranzini |
 |
Name: Dr. Clemens Gögele |
 |
Name: Dr. Rosario Amato |
 |
Name: Dr. Valentina Ricciardi |
 |
Name: Dr. Erin M. Harberts |
 |
Name: Dr. Guglielmo Puccio |
 |
Name: Dr. Zenia Kaul |
 |
Name: Dr. Jacopo Pizzicannella |
 |
Name: Dr. Xiaoqing Wang |
 |
Name: Dr. Dandan Wang |
 |
Name: Dr. Lizhong Liu |
 |
Name: Dr. Jia Huang |
 |
Name: Dr. Li Nie |
 |
Name: Dr. Ilaria D’Agostino |
 |
Name: Dr. Alessia Varone |
 |
Name: Dr. Marisa M. Merino |
 |
Name: Dr. Mei Yu |
 |
Name: Dr. Shahla Shojaei |
 |
Name: Dr. Francesco Gubinelli |
 |
Name: Dr. Wei Huang |
 |
Name: Dr. Amir Barzegar Behrooz |
 |
Name: Dr. Maria Villiou |
 |
Name: Dr. Yajin Zhao |
 |
Name: Dr. Eleni Tsakiri |
 |
Name: Dr. Muhammad Nauman Arshad |
 |
Name: Dr. Taxiarchis Katsinelos |
 |
Name: Dr. Syed Adeel H. Zaidi |
 |
Name: Dr. Martina Kunkl |
 |
Name: Dr. Maria Chatziathanasiadou |
 |
Name: Dr. Yohan Bignon |
 |
Name: Dalal Bakhos-Douaihy |
 |
Name: Dr. Puja Sohal |
 |
Name: Dr. Aida Shomali |
 |
Name: Dr. Giusi Alberti |
 |
Name: Dr. Junnan Li |
 |
Name: Dr Hannah Bolland |
 |
Name: Dr. Jonathan Paul Lambert |
 |
Name: Dr. Michela Carraro |
 |
Name: Dr. Panthipa Suwannakot |
 |
Name: Dr. Siddhesh Aras |
 |
Name: Dr. Satoko Shinjo |
 |
Name: Dr. Tiziano Mazza |
 |
Name: Dr. Arathyram Ramachandra Kurup Sasikala |
 |
Name: Dr. Sneha Swaroop |
 |
Name: Dr. Mudasir Ahmad Khanday |
 |
Name: Dr. Qin-Wei Wu |
17 February 2025
MDPI Celebrates Excellence in Medical Research with Early Career Researcher Awards
MDPI, a pioneer in scholarly open access publishing, and the Lee Kong Chian School of Medicine (LKCMedicine), Singapore, proudly announce the successful conclusion of the first edition the MDPI Early Career Researcher Awards. The awards, which recognize outstanding contributions to medical and biomedical research, were presented to six exceptional researchers during an awards ceremony held at LKCMedicine HQ Building on 28 November 2024.
|
|
|
Honoring Excellence in Research
The awards recognize exceptional postdoctoral researchers and Ph.D. students who have demonstrated outstanding originality, innovation, and impact in their respective fields. We are honored to announce the winners of the 2024 edition:
Early Career Researcher (Postdoc) Award:
- Dr. Theresia Handayani Mina, “Adiposity and Metabolic Health in Asian Populations: An Epidemiological Study Using Dual-Energy X-Ray Absorptiometry in Singapore”;
- Dr. Erfan Rezvani Ghomi, “Wound Healing Improvement by Novel Aligned Antimicrobial Nanofibrous 3D Scaffolds”;
- Dr. Yadollah Ranjbar Slamloo, “Functional Alterations of The Prefrontal Circuit Underlying Cognitive Aging in Mice”.
Early Career Researcher (Ph.D.) Award:
- Pritisha Rozario, “Mechanistic Basis for Potassium Efflux-Driven Activation of the Human NLRP1 Inflammasome”;
- Michelle Law Cheok Yien, “Chikungunya Virus Nonstructural Protein 1 is a Versatile RNA Capping and Decapping Enzyme”;
- Yin Ruoyu, “The Use of Digital Mental Health and Wellbeing Tools in Older Adults: A Mixed Method Study”.
Our collaboration highlights a shared commitment to recognizing exceptional talent and research within the academic community, addressing today’s healthcare challenges, and inspiring continued innovation.
|
|
|
|
|
|
|
|
|
Looking Ahead to 2025
Building on the success of the first edition, MDPI and LKCMedicine are excited to announce that the 2025 MDPI Early Researcher Awards will continue to celebrate excellence and innovation in medical research. The next edition promises to expand its scope, introducing new categories and providing even greater recognition for impactful research.
Further details on the 2025 awards, including nomination criteria and timelines, will be shared in the coming months. We remain committed to fostering a culture of research excellence and collaboration within the global scientific community.
|
|
5 February 2025
MDPI INSIGHTS: The CEO's Letter #20 - Beijing, Singapore, Bangkok, JAMS, Jisc
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
2024 Annual Meeting – Beijing (15 January 2025)
You haven’t truly experienced a New Year’s celebration until you’ve attended one of MDPI’s Chinese Annual Meeting festivities. This year I visited our annual meeting in Beijing, held on the 15th of January.
Imagine this: stepping into a banquet hall filled with 140 tables and about 1,400 colleagues from our Beijing offices, all gathered to share in a six-hour event. The agenda included year-end speeches and presentations, a variety of performances by our colleagues, a selection of awards honouring local employees for their work, group photos for the memories, and a dinner.
This may have been one of the largest events I have attended. For those unaccustomed to such an event, it might seem overwhelming, but it was quite the opposite. The atmosphere was one of celebration as everyone came together to support their peers and celebrate the achievements of 2024.
I was honoured to deliver the opening speech and a presentation highlighting our growth and investment in MDPI’s most valuable asset: our people.
“Our editorial teams represent MDPI at its finest”
I want to give special recognition to the editorial department, across all of our offices, which forms the heart of our business. These teams are the frontline communicators with our authors, reviewers, and guest editors, creating a smooth experience of processing our manuscripts. Their professionalism and kindness are often highlighted as key drivers of satisfaction with MDPI. For this, I extend my deepest gratitude to all our editorial staff, across every office. They truly represent MDPI at its finest.
Beijing is home to two of our offices, with just over 800 employees in Tongzhou and over 600 in Haidian. Thank you to our administrative teams and everyone involved in organizing these New Year’s celebrations across all offices. These events provide a moment to reflect on our shared accomplishments and appreciate the positive impact each of you has on our culture.
MDPI Offices in China
While the history of MDPI begins in Basel, Switzerland, the story of MDPI is very much rooted in China. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:
- 2008: Beijing (Tongzhou, Haidian)
- 2013: Wuhan (Hankou, Guanggu)
- 2019: Tianjin
- 2021: Dalian
- 2021: Nanjing
To date, over 381,000 MDPI research articles have been published by authors affiliated with Chinese institutions, making China our largest market. This is reflected not only in the volume of publications but also in the scale of our workforce supporting local operations and contributing to global success.
While no new offices in China were launched between 2022 and 2024 due to the pandemic and strategic planning, we remain committed to future growth here. Our plans include expanding operations as we continue to build our global workforce.
We look forward to a year filled with continued collaboration, growth, and shared success.
“We remain committed to future growth in China”
Impactful Research
MDPI and Jisc Consortium Extend Open Access Agreement for 2025
I’m pleased to share that MDPI has extended its agreement with the Jisc consortium in the UK for 2025. This renewal strengthens our partnership with UK institutions and reaffirms our shared commitment to advancing open access publishing.
Jisc is the UK’s not-for-profit digital, data, and technology agency supporting tertiary education, research, and innovation. Through initiatives such as our agreement, Jisc helps institutions access essential digital resources and infrastructure to support researchers. Currently, 62 UK institutions are part of our Institutional Open Access Program (IOAP) through this partnership.
Authors from participating institutions benefit from discounts on article processing charges (APCs), with even greater support for institutions that centrally fund APCs. This helps researchers focus on their work while simplifying the publishing process.
A full list of participating institutions can be found here.
As Becky Castellon, our Institutional Partnerships Manager, puts it: “Extending our agreement with Jisc is a reward for the strong partnership we’ve built with research institutions throughout the UK.”
At MDPI, we are dedicated to making research more accessible while reducing administrative burdens for institutions and authors. Open access publishing is at the heart of what we do, and we’re proud to expand its reach in the UK and beyond.
Inside MDPI
Visit to MDPI's Singapore office
During my January trip to some of our APAC offices, I also had the pleasure of visiting our Singapore office for the first time. It’s exciting to see how much the team has grown, now numbering over 55 staff members, with more joining us in February.
Welcoming and Supporting New Team Members
“Experienced staff play an important role in mentoring new hires”
I had the opportunity to connect with both experienced colleagues and new team members who are currently embarking on their careers. This visit reminded me of what it was like when I was in their shoes. I encourage all of us to engage new colleagues with empathy, as we have all been in their position. By creating a welcoming and supportive environment, we can help them settle in and learn about the corporate world, MDPI and our mission.
Experienced staff play an important role in mentoring and guiding new hires, most of whom are transitioning from academia to their first job. I’m especially grateful to colleagues such as Colin Chen, Alicia Ren, Yu Nwe Soe, Colin Wee, Amy Cham and other senior members who have contributed to shaping the culture and work environment in Singapore.
Building MDPI’s Positive Reputation
During my visit, I spoke with the office staff about the importance of their roles in building a positive reputation that helps create trust in MDPI. I shared how every interaction and communication point contributes to the marketing of MDPI and our journals. I also highlighted the career development opportunities available as MDPI continues to grow.
Connecting with the Singapore Marketing Team
I also spent time connecting directly with the Singapore Marketing team, which has quickly grown to 15 young and ambitious members. They are eager to learn and are actively contributing to our journal and corporate marketing activities. I shared insights into our corporate marketing structure and strategy and look forward to supporting them as they grow.
During the visit, I was joined by my colleague Dr. Constanze Schelhorn, Head of Indexing, who provided training on indexing. This training was greatly appreciated by the local staff.
Meeting with Prof. Dr. Manoj Gupta
Lastly, we had the privilege of meeting Prof. Dr. Manoj Gupta, Editor-in-Chief (EiC) of Technologies since 2016 and Section EiC of Metals.
Prof. Gupta is an active decision-maker for the journal and a great brand ambassador for MDPI.
Prof. Gupta has helped sustainably scale Technologies, which now has a 4.2 Impact Factor and a 6.7 CiteScore, ranking Q1 in the JCR category of Engineering and Q1 in the CiteScore category of Computer Science.
During our meeting, we discussed strategies for Institutional Open Access Partnership agreements and ways to promote MDPI journals in Singapore.
PS. During the visit, we also had the chance to participate in Lo Hei, also known as Yee Sang or the “prosperity toss.” This is a raw fish salad traditionally enjoyed during Chinese New Year and is particularly popular among Chinese communities in Singapore, Malaysia, and Indonesia. Everyone gathers around the table as the ingredients are added one by one, and then the salad is mixed together. It was a fun experience to take part in this New Year tradition!
Coming Together for Science
JAMS – Journal & Article Management System
I am excited to announce the official relaunch of JAMS (Journal & Article Management System), one of MDPI’s key initiatives to support academic publishers worldwide.
With this relaunch, JAMS now offers new pricing models and flexible solutions for small-scale journals, commercial publishers, and university presses. We have also redesigned the JAMS website to enhance the user experience.
“JAMS is a testament to our commitment to simplifying the publishing process”
Explore the new website here: jams.pub
It’s also great to see the JAMS team expanding our presence at conferences and on social media to engage more effectively with the academic community.
Recently, Facundo Santomé (Senior Marketing Manager) and Alex Ramos (Senior Marketing Specialist) represented JAMS at the APE 2025 conference in Berlin, highlighting how our platform empowers small and independent publishers to streamline and scale their journal management.
JAMS was built to change that by adapting to the unique requirements of each publisher.
At MDPI, we continually invest in our growth – not only by expanding our operations and staff but also by developing innovative products that serve the academic and publishing community at large. JAMS, with its comprehensive suite of journal management tools, is a testament to our commitment to simplifying the publishing process for our partners.
Imagine a submission system that frees up your time for strategy, innovation, and impactful publishing.
Under the leadership of Silvano Bonfatti (Product Manager, MDPI), the JAMS team has conducted in-depth market research to understand the challenges publishers face: endless administrative tasks, inefficient workflows, and systems that don’t always meet their needs.
If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.
What Sets JAMS Apart?
- Scalability – Whether you're a niche journal or managing thousands of submissions, JAMS grows with you.
- End-to-End Workflow – From submission to peer review and final publication, everything is in one place.
- Automation That Works for You – Say goodbye to chasing reviewers and formatting issues, so that you can focus on quality instead.
- Built by Publishers, for Publishers – JAMS is backed by MDPI’s expertise; we know exactly what it takes to run a journal smoothly.
- Flexible & Fair Pricing – Supporting journals of all sizes, with special rates for non-profits and publishers in the Global South.
Partners Who Already Trust JAMS
If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.
Closing Thoughts
Visit to MDPI's Bangkok office
To conclude my APAC trip, I had the pleasure of visiting our Bangkok office from 22 to 24 January. The office has grown significantly, closing 2024 with a total of 445 colleagues across various departments, including Editorial, Production, Conference, Training, Journal Relationship Specialists (JRS), Managing Editors, and supporting teams in HR, Admin, IT, and Finance.
I would like to praise our Bangkok management team for their excellent work in supporting our growth and creating a positive work environment. Our colleagues here are humble, talented, hardworking, and appreciative of MDPI’s mission.
Thailand was among MDPI’s top 30 markets in 2024 for total publications. With our office in Bangkok, we have an opportunity to further promote open access while supporting local researchers and institutions. This includes open access discounts, author training sessions, conference sponsorships, and other initiatives. We currently have 25 Editorial Board Members (EBMs) from Thailand and will work on expanding this network.
Engaging with Group Leads
“Group leads play an important role in creating a safe, positive environment”
During my visit, I met with our group leads to highlight their crucial role in managing journal performance and mentoring new employees, especially given our increased hiring targets. Many new hires are early in their careers and require training, development, and support. Group leads play an important role in creating a safe, positive environment that fosters professional growth while maintaining MDPI’s reputation for service quality.
To wrap up the session, I added a personal touch by holding the door and giving everyone high-fives – a small gesture to show appreciation, boost morale, and strengthen team spirit. It’s important for our colleagues to feel seen, heard, and valued.
University Visit: King Mongkut’s University of Technology North Bangkok (KMUTNB)
We also visited King Mongkut’s University of Technology North Bangkok (KMUTNB) to explore collaboration opportunities.
Our discussions focused on: Institutional Open Access Partnership (IOAP), Author training sessions, Conference sponsorships, Student employment initiatives, and more.
This visit reinforced the importance of building strong relationships with local universities, ensuring we continue to support and engage with the academic community in Thailand.
“My time in Bangkok was productive and inspiring”
My time in Bangkok was productive and inspiring. The senior team has done a great job in growing the office and creating a supportive, high-performing environment. I look forward to seeing continued success from our colleagues in Thailand.
Chief Executive Officer
MDPI AG
5 February 2025
Interview with Dr. Aleksandra Twarda-Cłapa—Winner of the Cells 2022 Best Paper Award
Dr. Aleksandra Twarda-Cłapa is an Assistant Professor at the Institute of Molecular and Industrial Biotechnology, Faculty of Biotechnology and Food Sciences, Lodz University of Technology, Poland. Her scientific interests focus on protein-protein/protein-ligand interactions and molecular as well as structural biology. During her scientific career, she participated in several exchanges and internships abroad, joining research groups in Germany, Finland, and Portugal, among others.
During her Ph.D. studies at Jagiellonian University in Krakow, Poland, she studied small-molecule inhibitors of the interactions of p53-MDM2/MDMX proteins with potential use in anticancer therapies. Since 2020, Dr. Aleksandra Twarda-Cłapa has been the principal investigator of the SONATINA grant focused on the stabilin-2 receptor and financed by the National Science Centre, Poland.
We had the pleasure of meeting her online and had a discussion in which we learned more about her background, views, and interests.
The following is a brief interview with Dr. Aleksandra Twarda-Clapa:
1. Could you give a brief introduction of yourself to the readers?
I am an Assistant Professor at the Institute of Molecular and Industrial Biotechnology, Lodz University of Technology in Poland. My scientific interests focus on protein-protein/protein-ligand interactions, as well as molecular and structural biology. Since 2020, I have been the principal investigator of the SONATINA project entitled “Chasing the HARE: characterization of the binding mechanism of new and unexplored ligands of the hyaluronic acid receptor, stabilin-2”, and financed by the National Science Centre, Poland.
2. Could you introduce your current research direction and progress?
My current research focuses on the human hyaluronic acid receptor, stabilin-2 (HARE/Stab2). This protein is involved in many physiological processes (e.g., removal of harmful substances from the bloodstream, such as the AGEs: advanced glycation end products) and pathological processes (e.g., diabetes, cancer). This receptor can potentially be used in precise drug delivery to cells, and the aim of the SONATINA project is, among others, to determine the three-dimensional structures of protein fragments.
3. Could you describe the difficulties and breakthrough innovations in this research field?
One of the remaining biggest challenges in my field is obtaining high amounts of pure protein preparations that can then be crystallized. This brings us to the next bottleneck, i.e., the crystallization process.
Concerning breakthrough innovations in structural biology, it is definitely the development of the cryoEM method for the determination of three-dimensional structures of biomolecules.
4. What appealed to you about Cells that made you want to submit your paper? And how was your experience submitting to Cells?
I had to find a journal that would accept such a broad review manuscript. The short time from submission to decision was another factor. The submission process is, in my opinion, user-friendly.
5. Do you have any advice for aspiring young researchers looking to make a meaningful impact in their respective fields?
Do not give up easily; often, the most important results appear in the end. I would also like to encourage young mothers who took a break to give birth and raise their children to return to their scientific careers, despite the difficulties.
We would like to congratulate Dr. Aleksandra Twarda-Cłapa on winning the Cells 2022 Best Paper Award!
4 February 2025
World Cancer Day 2025—United in Every Journey
Cancer impacts millions of lives worldwide, yet each person’s journey with the disease is uniquely their own. World Cancer Day reminds us that while the disease impacts individuals differently, our shared strength, innovation, and focus on holistic care bring us closer to a future where cancer no longer dictates lives. Every experience, challenge, and success story contribute to the broader fight against cancer, demonstrating the resilience and hope that unite us all. As we continue to make strides through innovative research, treatment advancements, and global collaboration, it is essential to recognize both the diversity of stories and our common goal of overcoming cancer together.
In observance of this day, we invite you to explore the following resources that delve into the field of cancer and the cutting-edge advancements shaping its care. By prioritizing people-centered treatment where patients’ voices and needs guide care, we can ensure personalized attention for all. It is our hope to foster a deeper understanding of the impact of cancer and encourage meaningful action to support patients, caregivers, and researchers in their pursuit of a world free from cancer’s hold. Together, we can inspire action and work toward a cancer-free future.
 |
|
Biology & Life Sciences |
Medicine & Pharmacology |
Chemistry & Material Sciences Public Health & Healthcare Engineering Society |
 |
“Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls”
by Celestine M. Trinidad, Sintawat Wangsiricharoen, Victor G. Prieto and Phyu P. Aung
Dermatopathology 2023, 10(1), 54–62; https://doi.org/10.3390/dermatopathology10010008
“Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective”
by Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria Grishina et al.
Pharmaceuticals 2023, 16(2), 299; https://doi.org/10.3390/ph16020299
“Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine”
by Maurizio Cè, Giovanni Irmici, Chiara Foschini, Giulia Maria Danesini, Lydia Viviana Falsitta, Maria Lina Serio, Andrea Fontana, Carlo Martinenghi, Giancarlo Oliva and Michaela Cellina
Curr. Oncol. 2023, 30(3), 2673–2701; https://doi.org/10.3390/curroncol30030203
“Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook”
by Onyinyechi Obidiro, Gantumur Battogtokh and Emmanuel O. Akala
Pharmaceutics 2023, 15(7), 1796; https://doi.org/10.3390/pharmaceutics15071796
“Biomarkers in Breast Cancer: An Old Story with a New End”
by Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, Matheus Correia Casotti, Diego do Prado Ventorim, Jucimara Ferreira Figueiredo Almeida, Valdemir Pereira de Sousa, Marllon Cindra Sant’Ana, Rahna Gonçalves Coutinho da Cruz, Luana Santos Louro et al.
Genes 2023, 14(7), 1364; https://doi.org/10.3390/genes14071364
“Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?”
by Marin Golčić and Andrej Belančić
Diabetology 2023, 4(4), 553–559; https://doi.org/10.3390/diabetology4040049
“Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers”
by Ravi Bharadwaj, Swati Jaiswal, Erandi E. Velarde de la Cruz and Ritesh P. Thakare
Diseases 2024, 12(3), 63; https://doi.org/10.3390/diseases12030063
“Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer”
by Dimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki and Konstantinos G. Toutouzas
Curr. Issues Mol. Biol. 2024, 46(4), 2827–2844; https://doi.org/10.3390/cimb46040177
“Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies”
by Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, Jorge Sastre-Serra, Daniel Gabriel Pons, Adamo Valle, Pilar Roca and Mercedes Nadal-Serrano
Biology 2024, 13(5), 302; https://doi.org/10.3390/biology13050302
“Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions”
by Abdullah Younis and John Gribben
Immuno 2024, 4(3), 186–210; https://doi.org/10.3390/immuno4030013
“Breast Cancer Screening among African Immigrants in the United States: An Integrative Review of Barriers, Facilitators, and Interventions”
by Julian I. Rauch, Joseph Daniels, Alyssa Robillard and Rodney P. Joseph
Int. J. Environ. Res. Public Health 2024, 21(8), 1004; https://doi.org/10.3390/ijerph21081004
“Predicting Leukoplakia and Oral Squamous Cell Carcinoma Using Interpretable Machine Learning: A Retrospective Analysis”
by Salem Shamsul Alam, Saif Ahmed, Taseef Hasan Farook and James Dudley
Oral 2024, 4(3), 386–404; https://doi.org/10.3390/oral4030032
 |
 |
 |
 |
 |
27 January 2025
Acknowledgment to the Reviewers of Cells in 2024
